Revance Therapeutics Inc Revenue per Employee (RVNC), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Revance Therapeutics Inc   (NASDAQ: RVNC)
 

Revance Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 5.47% in the third quarter 2024, year on year to cumulative value of $247 million, Revance Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 462,552, this marks a new company high.
Within the Healthcare sector Employees of 124 other companies have achieved higher revenue per employee. While Revance Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 809 to 1186. Revance Therapeutics Inc has 534 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RVNC Revenue per Employee (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Revenue Change 5.47 % 12.48 % 5.28 % 39.82 % 95.68 %
Sales per Employee (TTM) $ 462,552 456,742 443,155 438,277 401,052
RVNC's Total Ranking # 1186 # 809 # 743 # 716 # 877
Seq. Revenue Change -8.43 % 25.9 % -25.59 % 22.94 % -2.34 %

RVNC Company Profile >> Back to RVNC Efficiency Comparisons >> Compare RVNC Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 70
Healthcare Sector # 125
Overall Market # 1186

Revenue per Employee Statistics
High Average Low
$ 462,552 $ 132,904 $ 491
(Sep 30 2024)   (Dec 31 2017)



Financial Statements
Revance Therapeutics Inc 's Revenue MRQ $ 60 Millions Visit RVNC's Income Statement
Revance Therapeutics Inc 's Revenues TTM $ 247 Millions Visit RVNC's aggregate revenue growth
What are RVNC's Sales? Visit RVNC's Sales by Segment




Other Ratios
Revance Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
RVNC's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for RVNC's Competitors
Revenue per Employee for RVNC's Suppliers
Revenue per Employee for RVNC's Customers

You may also want to know
RVNC's Sales Growth Rates RVNC's Pe Price to earnings ratio RVNC's Receivables Turnover Ratio RVNC's Stock Quote
RVNC's Net Income Growth Rates RVNC's Ps Price to Sales ratio RVNC's Sales per Employee RVNC's Asset Turnover Ratio
RVNC's Net Margin RVNC's Pb Price to Book ratio RVNC's Financial Strength Ratios RVNC's Dividend Payout Ratio
Date modified: 2026-08-29T17:18:21+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2024Number of Employees Sep 30 2024
Avadel Pharmaceuticals Plc  806,857.14 $ 124.256  Million 154 
Pfizer Inc  801,493.33 $ 60,112.000  Million 75,000 
Fortress Biotech Inc   801,294.87 $ 62.501  Million 78 
Biolife Solutions Inc   795,858.06 $ 123.358  Million 155 
Veru Inc   790,678.10 $ 15.814  Million 20 
Eton Pharmaceuticals Inc   763,795.45 $ 33.607  Million 44 
Blueprint Medicines Corporation  756,414.09 $ 440.233  Million 582 
Xtant Medical Holdings Inc   747,827.81 $ 112.922  Million 151 
Arcellx Inc   745,540.67 $ 155.818  Million 209 
Evolus Inc   743,491.02 $ 248.326  Million 334 
Ati Physical Therapy Inc   741,863.00 $ 741.863  Million 1,000 
Alkermes Plc   734,205.37 $ 1,505.121  Million 2,050 
Tvardi Therapeutics Inc   723,833.33 $ 8.686  Million 12 
Inmed Pharmaceuticals Inc  714,016.67 $ 4.284  Million 6 
Adaptimmune Therapeutics Plc  711,548.78 $ 175.041  Million 246 
Editas Medicine Inc   709,862.07 $ 61.758  Million 87 
Sanara Medtech Inc   706,040.12 $ 76.252  Million 108 
Theravance Biopharma inc   702,133.33 $ 63.192  Million 90 
Sensus Healthcare Inc   688,450.00 $ 41.307  Million 60 
Beam Therapeutics Inc   684,232.88 $ 349.643  Million 511 
Dyadic International Inc   672,909.60 $ 3.365  Million 5 
Biofrontera Inc   667,739.13 $ 61.432  Million 92 
Tg Therapeutics Inc   663,631.58 $ 264.789  Million 399 
Sunshine Biopharma Inc   659,189.84 $ 32.959  Million 50 
Dih Holding Us Inc   656,146.07 $ 116.794  Million 178 
Arvinas Inc   654,878.05 $ 161.100  Million 246 
Karyopharm Therapeutics Inc   651,061.40 $ 148.442  Million 228 
Organon and Co   640,900.00 $ 6,409.000  Million 10,000 
Cartesian Therapeutics Inc   639,173.33 $ 47.938  Million 75 
Maravai Lifesciences Holdings Inc   636,597.70 $ 276.920  Million 435 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.